Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Antiretroviral DAD isosteres and HIV protease inhibitors claimed by HHS

July 2, 1998

First report of efficacy for a CCR5 antagonist in an animal model of HIV infection

July 2, 1998

Pentoxifylline as an effective treatment for chronic ulceration in HIV patients

July 2, 1998

Agouron continues to expand anti-HIV pipeline

July 1, 1998

Significant anti-HIV activity seen with Ziagen plus protease inhibitors

July 1, 1998

Agouron in-licenses S-1153; phase I results presented at AIDS conference

June 30, 1998

U.K. introduction for Viracept

June 30, 1998

Hydroxyurea in combination regimens enhances anti-HIV activity

June 30, 1998

Early studies with JE-2147 yield promising results

June 30, 1998

Two-year landmark study demonstrates importance of initiating triple therapy simultaneously

June 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...